Covered recipient · General Payments record
GREGORY AUSTIN
Allopathic & Osteopathic Physicians Family Medicine
This page merges CMS profile IDs 8800663, 93997 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2018–2020
$1,509.95
- Reported across 128 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.44 | 14 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $46.60 | 3 |
| PFIZER INC. | $26.37 | 2 |
| GlaxoSmithKline, LLC. | $23.48 | 2 |
| Janssen Pharmaceuticals, Inc | $19.14 | 1 |
| Amarin Pharma Inc. | $15.02 | 1 |
| Lilly USA, LLC | $14.55 | 1 |
| Amgen Inc. | $13.92 | 1 |
| Astellas Pharma US Inc | $12.70 | 1 |
| Allergan Inc. | $12.47 | 1 |
| Merck Sharp & Dohme Corporation | $12.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Allergan, Inc. | $12.47 | 06/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 723355225 | CMS |
| Amarin Pharma Inc. | $15.02 | 03/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 739896783 | CMS |
| Amgen Inc. | $13.92 | 02/26/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741064819 | CMS |
| Astellas Pharma US Inc | $12.70 | 02/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 718296133 | CMS |
| GlaxoSmithKline, LLC. | $12.23 | 01/06/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738768921 | CMS |
| GlaxoSmithKline, LLC. | $11.25 | 03/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738593773 | CMS |
| Janssen Pharmaceuticals, Inc | $19.14 | 01/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 719159855 | CMS |
| Lilly USA, LLC | $14.55 | 03/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728438849 | CMS |
| Merck Sharp & Dohme Corporation | $12.19 | 01/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 747731939 | CMS |
| Novo Nordisk Inc | $19.42 | 01/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 745450899 | CMS |
| Novo Nordisk Inc | $16.14 | 01/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 745450903 | CMS |
| Novo Nordisk Inc | $11.04 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 745450905 | CMS |
| PFIZER INC. | $13.80 | 02/19/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743676773 | CMS |
| PFIZER INC. | $12.57 | 02/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743676777 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
- Merged CMS profile IDs
- 8800663, 93997
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.